Stock_Titan Posted - 2 months ago

$DXR Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management https://www.stocktitan.net/news/DXR/newly-published-review-highlights-the-pivotal-role-of-daxor-s-blood-fgi89kbn3ev2.html

Stock_Titan Posted - 2 months ago

$DXR Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care https://www.stocktitan.net/news/DXR/leading-central-florida-hospital-implements-daxor-s-bva-100-blood-lxdzqcxjs8yn.html

Stock_Titan Posted - 2 months ago

$DXR Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter https://www.stocktitan.net/news/DXR/daxor-corporation-ceo-and-president-michael-feldschuh-delivers-2ilo8uzpeq8l.html

GambitMentality Posted - 08/30/24

Today’s #StockMarket EOD Biggest Losers by %, led by $ESTC $ACAC and $DXR to lead the TOP 3

GambitMentality Posted - 08/29/24

Today’s #StockMarket EOD Biggest Gainers by %, led by $AFRM $SKIL and $DXR to lead the TOP 3

LewisDaKat Posted - 08/29/24

$DXR News Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network https://marketwirenews.com/news-releases/daxor-corporation-announces-launch-of-bva-program-at-4848829962805662.html $DXR

Stock_Titan Posted - 08/29/24

$DXR Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network https://www.stocktitan.net/news/DXR/daxor-corporation-announces-launch-of-bva-program-at-mid-south-uwf8c4i5c8zu.html

akts Posted - 3 months ago

$DXR turtles crawl faster than this company makes progress. Will it be 2026 or 2027 when we get DXR in gear?

Stock_Titan Posted - 3 months ago

$DXR Daxor Corporation Awarded $1.9M Contract by The U.S. Air Force for Development of its Next Generation Tracer System in its Point-of-Care Blood Volume Analyzer https://www.stocktitan.net/news/DXR/daxor-corporation-awarded-1-9m-contract-by-the-u-s-air-force-for-3myt6j6x197w.html

Stock_Titan Posted - 3 months ago

$DXR Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide https://www.stocktitan.net/news/DXR/daxor-expands-to-three-new-facilities-as-blood-volume-analysis-tvazm3ubi4hu.html

PenkeTrading Posted - 3 months ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Daxor Corporation. Is that bullish or bearish? $DXR #DXR #nasdaq #tradingsignals #technicalanalysis

NVDAMillionaire Posted - 3 months ago

$DXR Daxor Corporation (DXR): Revolutionizing Blood Volume Measurement and Driving Improved Patient Outcomes http://beyondspx.com/2024/08/01/daxor-corporation-dxr-revolutionizing-blood-volume-measurement-and-driving-improved-patient-outcomes/

BioTuesdays Posted - 07/24/24

Daxor awarded new U.S. DHA contract for blood volume analyzer upgrade $DXR https://biotuesdays.com/2024/07/24/daxor-awarded-new-u-s-dha-contract-for-blood-volume-analyzer-upgrade/

DonCorleone77 Posted - 07/24/24

$DXR Daxor awarded $550K matching-fund extension from U.S. DHA Daxor Corporation announces that Daxor has received a $550K matching-fund extension from the U.S. Defense Health Agency to its Phase II SBIR contract. This additional funding will support adding hematocrit measurement to a future generation blood volume analyzer. The upgrade eliminates the need for hematocrit testing from third-party devices to perform the BVA test.

Stock_Titan Posted - 07/24/24

$DXR Daxor Corporation Awarded New U.S. Defense Health Agency Contract for Added Capabilities to Its Point-of-Care Blood Volume Analyzer https://www.stocktitan.net/news/DXR/daxor-corporation-awarded-new-u-s-defense-health-agency-contract-for-2pllu73wwvtr.html

NVDAMillionaire Posted - 4 months ago

$DXR Daxor Corporation: Pioneering Blood Volume Analysis for Improved Patient Outcomes http://beyondspx.com/2024/07/12/daxor-corporation-pioneering-blood-volume-analysis-for-improved-patient-outcomes/

HorsePicks Posted - 4 months ago

$DXR Daxor Corporation's BVA-100 Blood Volume Diagnostic Expands To Three New Centers, Gains Traction Nationwide

Stock_Titan Posted - 4 months ago

$DXR Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide https://www.stocktitan.net/news/DXR/daxor-corporation-s-bva-100-blood-volume-diagnostic-expands-to-three-zircnljaixnq.html

Stock_Titan Posted - 5 months ago

$DXR Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting https://www.stocktitan.net/news/DXR/daxor-corporation-to-showcase-the-benefits-of-bva-100-guided-care-at-jswttxofiacf.html

Stock_Titan Posted - 7 months ago

$DXR New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion https://www.stocktitan.net/news/DXR/new-studies-prove-the-clinical-benefits-of-daxor-s-blood-volume-bva-u929s9oh6jgw.html

Stock_Titan Posted - 7 months ago

$DXR DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™) https://www.stocktitan.net/news/DXR/daxor-corporation-to-exhibit-at-the-medaxiom-cardiovascular-1lh4kl6wtlmc.html

Qutiaw Posted - 7 months ago

$ICU Could there be a Daxor ($DXR) relation with ICU?

Stock_Titan Posted - 7 months ago

$DXR Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital https://www.stocktitan.net/news/DXR/daxor-corporation-announces-new-hospital-account-at-leading-chicago-71ylzg628hml.html

Stock_Titan Posted - 7 months ago

$DXR Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24 https://www.stocktitan.net/news/DXR/daxor-corporation-to-exhibit-at-the-american-college-of-cardiology-vjaf3z5e07y2.html

insiderbuyingselling Posted - 03/27/24

$DXR new insider buying: 750 shares. http://insiderbuyingselling.com/?t=DXR

DonCorleone77 Posted - 03/25/24

$DXR Daxor acquires Volumex, Megatope for Iso-Tex Diagnostics Daxor entered into a definitive agreement to acquire exclusive and worldwide rights and intellectual property to manufacture from its existing supplier for Volumex and Megatope from privately-held Iso-Tex Diagnostics, Inc. Daxor has also acquired the exclusive rights to Glofil, a drug that measures glomerular filtration rate, which Iso-Tex has been selling directly to its customer base. Daxor projects the acquisitions to be cash flow positive and accretive to earnings immediately upon transfer of the manufacturing. This is due to the embedded revenue streams of the drugs and significantly higher margins that will be achieved with internalized production. The deals have been structured with seller-provided financing on favorable terms. No payments will come due until manufacturing is fully transitioned to Daxor over the next 6-9 months. The total transaction value will then be paid in monthly installments over two years...

Stock_Titan Posted - 03/25/24

$DXR Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics https://www.stocktitan.net/news/DXR/daxor-corporation-acquires-volumex-r-and-megatope-r-from-its-kx28m80c8d53.html

Stock_Titan Posted - 7 months ago

$DXR Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 https://www.stocktitan.net/news/DXR/daxor-corporation-to-hold-investor-call-discussing-fiscal-year-2023-f4jkn416ziua.html

DutchVH Posted - 8 months ago

$DXR

Stock_Titan Posted - 8 months ago

$DXR Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders https://www.stocktitan.net/news/DXR/daxor-corporation-ceo-and-president-michael-feldschuh-provides-ap54lpwofuvc.html